vs
AIR LEASE CORP（AL）与Esperion Therapeutics, Inc.（ESPR）财务数据对比。点击上方公司名可切换其他公司
Esperion Therapeutics, Inc.的季度营收约是AIR LEASE CORP的1.2倍（$168.4M vs $140.8M），Esperion Therapeutics, Inc.同比增速更快（143.7% vs 90.4%），过去两年AIR LEASE CORP的营收复合增速更高（69.6% vs 10.6%）
航空租赁公司（ALC）是2010年成立的美国飞机租赁企业，由史蒂文·F·乌德瓦-哈齐执掌运营。公司直接向波音、空客、巴航工业、ATR采购全新商用飞机，为全球各地航空公司客户提供专业的飞机租赁及融资服务。
Esperion Therapeutics, Inc.是一家上市美国药企，专注开发用于降低低密度脂蛋白胆固醇的口服小分子药物苯哌多酸，公司总部位于密歇根州安娜堡，目前核心研发管线围绕这款降脂创新药物推进，深耕血脂异常治疗领域的创新药物开发。
AL vs ESPR — 直观对比
营收规模更大
ESPR
是对方的1.2倍
$140.8M
营收增速更快
ESPR
高出53.3%
90.4%
两年增速更快
AL
近两年复合增速
10.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $140.8M | $168.4M |
| 净利润 | $180.9M | — |
| 毛利率 | — | — |
| 营业利润率 | — | 50.6% |
| 净利率 | 128.5% | — |
| 营收同比 | 90.4% | 143.7% |
| 净利润同比 | 60.2% | — |
| 每股收益（稀释后） | $1.49 | $0.32 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ALESPR
| Q4 25 | $140.8M | $168.4M | ||
| Q3 25 | $44.5M | $87.3M | ||
| Q2 25 | $53.0M | $82.4M | ||
| Q1 25 | $92.9M | $65.0M | ||
| Q4 24 | $74.0M | $69.1M | ||
| Q3 24 | $65.0M | $51.6M | ||
| Q2 24 | $57.8M | $73.8M | ||
| Q1 24 | $49.0M | $137.7M |
净利润ALESPR
| Q4 25 | $180.9M | — | ||
| Q3 25 | $146.5M | $-31.3M | ||
| Q2 25 | $385.2M | $-12.7M | ||
| Q1 25 | $375.8M | $-40.5M | ||
| Q4 24 | $112.9M | — | ||
| Q3 24 | $104.0M | $-29.5M | ||
| Q2 24 | $102.9M | $-61.9M | ||
| Q1 24 | $107.9M | $61.0M |
营业利润率ALESPR
| Q4 25 | — | 50.6% | ||
| Q3 25 | — | -11.4% | ||
| Q2 25 | — | 8.6% | ||
| Q1 25 | — | -34.0% | ||
| Q4 24 | — | -6.4% | ||
| Q3 24 | — | -31.0% | ||
| Q2 24 | — | 3.5% | ||
| Q1 24 | — | 52.5% |
净利率ALESPR
| Q4 25 | 128.5% | — | ||
| Q3 25 | 329.2% | -35.9% | ||
| Q2 25 | 726.9% | -15.4% | ||
| Q1 25 | 404.5% | -62.2% | ||
| Q4 24 | 152.7% | — | ||
| Q3 24 | 160.0% | -57.2% | ||
| Q2 24 | 178.2% | -83.9% | ||
| Q1 24 | 220.2% | 44.3% |
每股收益（稀释后）ALESPR
| Q4 25 | $1.49 | $0.32 | ||
| Q3 25 | $1.21 | $-0.16 | ||
| Q2 25 | $3.33 | $-0.06 | ||
| Q1 25 | $3.26 | $-0.21 | ||
| Q4 24 | $0.83 | $-0.14 | ||
| Q3 24 | $0.82 | $-0.15 | ||
| Q2 24 | $0.81 | $-0.33 | ||
| Q1 24 | $0.87 | $0.34 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $466.4M | $167.9M |
| 总债务越低越好 | $19.7B | — |
| 股东权益账面价值 | $8.5B | $-302.0M |
| 总资产 | $32.9B | $465.9M |
| 负债/权益比越低杠杆越低 | 2.33× | — |
8季度趋势，按日历期对齐
现金及短期投资ALESPR
| Q4 25 | $466.4M | $167.9M | ||
| Q3 25 | $452.2M | $92.4M | ||
| Q2 25 | $454.8M | $86.1M | ||
| Q1 25 | $456.6M | $114.6M | ||
| Q4 24 | $472.6M | $144.8M | ||
| Q3 24 | $460.8M | $144.7M | ||
| Q2 24 | $454.1M | $189.3M | ||
| Q1 24 | $554.4M | $226.6M |
总债务ALESPR
| Q4 25 | $19.7B | — | ||
| Q3 25 | $20.2B | — | ||
| Q2 25 | $20.3B | — | ||
| Q1 25 | $19.9B | — | ||
| Q4 24 | $20.2B | — | ||
| Q3 24 | $20.2B | — | ||
| Q2 24 | $19.7B | — | ||
| Q1 24 | $19.5B | — |
股东权益ALESPR
| Q4 25 | $8.5B | $-302.0M | ||
| Q3 25 | $8.3B | $-451.4M | ||
| Q2 25 | $8.2B | $-433.5M | ||
| Q1 25 | $7.9B | $-426.2M | ||
| Q4 24 | $7.5B | $-388.7M | ||
| Q3 24 | $7.7B | $-370.2M | ||
| Q2 24 | $7.3B | $-344.2M | ||
| Q1 24 | $7.2B | $-294.3M |
总资产ALESPR
| Q4 25 | $32.9B | $465.9M | ||
| Q3 25 | $33.4B | $364.0M | ||
| Q2 25 | $33.3B | $347.1M | ||
| Q1 25 | $32.4B | $324.0M | ||
| Q4 24 | $32.3B | $343.8M | ||
| Q3 24 | $32.2B | $314.1M | ||
| Q2 24 | $31.0B | $352.3M | ||
| Q1 24 | $30.9B | $373.1M |
负债/权益比ALESPR
| Q4 25 | 2.33× | — | ||
| Q3 25 | 2.42× | — | ||
| Q2 25 | 2.47× | — | ||
| Q1 25 | 2.53× | — | ||
| Q4 24 | 2.68× | — | ||
| Q3 24 | 2.63× | — | ||
| Q2 24 | 2.69× | — | ||
| Q1 24 | 2.69× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $414.1M | $45.2M |
| 自由现金流经营现金流 - 资本支出 | $342.1M | — |
| 自由现金流率自由现金流/营收 | 242.9% | — |
| 资本支出强度资本支出/营收 | 51.1% | 0.0% |
| 现金转化率经营现金流/净利润 | 2.29× | — |
| 过去12个月自由现金流最近4个季度 | $1.5B | — |
8季度趋势，按日历期对齐
经营现金流ALESPR
| Q4 25 | $414.1M | $45.2M | ||
| Q3 25 | $458.6M | $-4.3M | ||
| Q2 25 | $473.6M | $-31.4M | ||
| Q1 25 | $388.3M | $-22.6M | ||
| Q4 24 | $430.0M | $-35.0M | ||
| Q3 24 | $461.9M | $-35.3M | ||
| Q2 24 | $413.8M | $-7.2M | ||
| Q1 24 | $371.3M | $53.8M |
自由现金流ALESPR
| Q4 25 | $342.1M | — | ||
| Q3 25 | $412.3M | — | ||
| Q2 25 | $427.1M | — | ||
| Q1 25 | $315.5M | — | ||
| Q4 24 | $326.8M | — | ||
| Q3 24 | $369.8M | $-35.5M | ||
| Q2 24 | $346.4M | $-7.3M | ||
| Q1 24 | $246.8M | $53.8M |
自由现金流率ALESPR
| Q4 25 | 242.9% | — | ||
| Q3 25 | 926.6% | — | ||
| Q2 25 | 806.0% | — | ||
| Q1 25 | 339.5% | — | ||
| Q4 24 | 441.8% | — | ||
| Q3 24 | 569.1% | -68.7% | ||
| Q2 24 | 599.5% | -9.9% | ||
| Q1 24 | 503.8% | 39.0% |
资本支出强度ALESPR
| Q4 25 | 51.1% | 0.0% | ||
| Q3 25 | 104.1% | 0.0% | ||
| Q2 25 | 87.8% | 0.0% | ||
| Q1 25 | 78.4% | 0.0% | ||
| Q4 24 | 139.6% | 0.0% | ||
| Q3 24 | 141.7% | 0.3% | ||
| Q2 24 | 116.7% | 0.1% | ||
| Q1 24 | 254.3% | 0.1% |
现金转化率ALESPR
| Q4 25 | 2.29× | — | ||
| Q3 25 | 3.13× | — | ||
| Q2 25 | 1.23× | — | ||
| Q1 25 | 1.03× | — | ||
| Q4 24 | 3.81× | — | ||
| Q3 24 | 4.44× | — | ||
| Q2 24 | 4.02× | — | ||
| Q1 24 | 3.44× | 0.88× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AL
暂无分部数据
ESPR
| Collaboration Revenue | $124.7M | 74% |
| Products | $43.7M | 26% |
